Status:

TERMINATED

Duration of GnRH-analogue Downregulation and Pregnancy Rates

Lead Sponsor:

Aristotle University Of Thessaloniki

Conditions:

Infertility

Eligibility:

FEMALE

19-38 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to assess whether the probability of pregnancy is dependent on the duration of GnRH agonist downregulation in IVF cycles.

Detailed Description

GnRH agonists have been used extensively in assisted reproduction technologies for inhibition of gonadotropin secretion from the pituitary prior to initiation of ovarian stimulation. Administration of...

Eligibility Criteria

Inclusion

  • age under 39
  • less than 3 previous IVF cycles
  • BMI 18-29
  • normal ultrasound of internal genital organs

Exclusion

  • polycystic ovarian syndrome
  • endometriosis

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00436319

Start Date

May 1 2006

Last Update

February 12 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Unit of Human Reproduction, 1st Department of Obst & Gyn, Aristotle University of Thessaloniki, Papageorgiou Hospital, Greece

Thessaloniki, Greece

Duration of GnRH-analogue Downregulation and Pregnancy Rates | DecenTrialz